article thumbnail

Abstract WP13: Determining Eligible Thrombolysis Candidates for Isolated Dizziness

Stroke Journal

Stroke, Volume 56, Issue Suppl_1 , Page AWP13-AWP13, February 1, 2025. We aimed to create a protocol that identifies thrombolysis candidates for patients presenting with isolated dizziness.Methods:A code stroke activation protocol was implemented by the Rhode Island Hospital Stroke Committee in 08/2021. in 2021, 37.5

article thumbnail

Abstract TMP33: Recanalization of intracranial vessel occlusion in Acute Ischemic Stroke and Thrombolysis “Dwell Time”

Stroke Journal

Stroke, Volume 56, Issue Suppl_1 , Page ATMP33-ATMP33, February 1, 2025. Thrombolysis at the spoke hospital with the patient transferred to the hub for MT is a model known as drip-and-ship. Thrombolysis dwell time was defined as the timefrom administration of thrombolysis to repeat vascular imaging. years (range, 25.1

article thumbnail

Abstract WMP118: Thrombin generation is associated with outcome in patients with stroke treated with thrombolysis

Stroke Journal

Stroke, Volume 56, Issue Suppl_1 , Page AWMP118-AWMP118, February 1, 2025. Properties of the formed thrombus may influence thrombolysis efficiency and impede recanalization success. Properties of the formed thrombus may influence thrombolysis efficiency and impede recanalization success.

article thumbnail

Abstract WP1: Intravenous Thrombolysis for Central Retinal Artery Occlusion in Routine Clinical Practice

Stroke Journal

Stroke, Volume 56, Issue Suppl_1 , Page AWP1-AWP1, February 1, 2025. One of the considered and currently increasingly preferred options is intravenous thrombolysis. According to our data, intravenous thrombolysis is also an effective and safe therapy here. There is still no definite recommendation for treatment.

article thumbnail

Abstract TP25: Benefits and Risks of Antiplatelet Versus Thrombolysis for Mild Acute Ischemic Stroke: Update of a Living Systematic Review and Meta-analysis

Stroke Journal

Stroke, Volume 56, Issue Suppl_1 , Page ATP25-ATP25, February 1, 2025. Background:Previous study found that compared with thrombolysis, antiplatelet did not improve outcomes but reduce the risk of symptomatic intracranial hemorrhage(sICH) for mild acute ischemic stroke(AIS) defined as National Institutes of Health Stroke Scale score 0 to 5.

article thumbnail

Abstract WP11: Efficacy and Safety Outcomes of thrombolysis for stroke in Low- and Middle-Income countries: Systematic Review and Metanalysis

Stroke Journal

Stroke, Volume 56, Issue Suppl_1 , Page AWP11-AWP11, February 1, 2025. Introduction:Stroke is a leading cause of disability and mortality worldwide, with thrombolysis as a critical treatment. Studies aiming to assess the outcomes of thrombolysis after ischemic stroke in LMIC were selected.

article thumbnail

Abstract DP4: When Does Clinical Worsening Begin in Symptomatic Intracranial Hemorrhage after Intravenous Thrombolysis?

Stroke Journal

Stroke, Volume 56, Issue Suppl_1 , Page ADP4-ADP4, February 1, 2025. Introduction:Intravenous thrombolysis with alteplase (tPA) or tenecteplase (TNK) is a first-line treatment for acute ischemic stroke. The most serious risk associated with IV thrombolytics is symptomatic intracranial hemorrhage (sICH).